Global Hepatitis B Vaccines Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Hepatitis B Vaccines market size will reach 1,590.27 Million USD in 2025 and is projected to reach 2,570.38 Million USD by 2032, with a CAGR of 7.10% (2025-2032). Notably, the China Hepatitis B Vaccines market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Hepatitis B vaccines are preventive immunizations designed to provide protection against the Hepatitis B virus, which can cause a potentially serious liver infection. The vaccines work by stimulating the immune system to produce antibodies that provide immunity to the virus. Hepatitis B is commonly transmitted through contact with infected blood, unprotected sexual activity, or from an infected mother to her newborn during childbirth. The Hepatitis B vaccine is typically administered in a series of three or four shots, with the second dose given one month after the first, the third dose given six months after the first, and a booster shot recommended in certain situations. Vaccination is recommended for individuals at risk of Hepatitis B exposure, including healthcare workers, people with multiple sexual partners, newborns of infected mothers, and individuals with certain medical conditions. Hepatitis B vaccination has been highly successful in preventing new infections and reducing the long-term risks associated with Hepatitis B, such as chronic liver disease and liver cancer.
The major global manufacturers of Hepatitis B Vaccines include GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, Serum Institute, LG Life Sciences, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Hepatitis B Vaccines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Hepatitis B Vaccines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Hepatitis B Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Hepatitis B Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Hepatitis B Vaccines Include:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
Serum Institute
LG Life Sciences
Hepatitis B Vaccines Product Segment Include:
Yeast Derived
CHO Derived
Hepatitis B Vaccines Product Application Include:
Children
Adult
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Hepatitis B Vaccines Industry PESTEL Analysis
Chapter 3: Global Hepatitis B Vaccines Industry Porter's Five Forces Analysis
Chapter 4: Global Hepatitis B Vaccines Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Hepatitis B Vaccines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Hepatitis B Vaccines Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Hepatitis B Vaccines Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Hepatitis B Vaccines market size will reach 1,590.27 Million USD in 2025 and is projected to reach 2,570.38 Million USD by 2032, with a CAGR of 7.10% (2025-2032). Notably, the China Hepatitis B Vaccines market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Hepatitis B vaccines are preventive immunizations designed to provide protection against the Hepatitis B virus, which can cause a potentially serious liver infection. The vaccines work by stimulating the immune system to produce antibodies that provide immunity to the virus. Hepatitis B is commonly transmitted through contact with infected blood, unprotected sexual activity, or from an infected mother to her newborn during childbirth. The Hepatitis B vaccine is typically administered in a series of three or four shots, with the second dose given one month after the first, the third dose given six months after the first, and a booster shot recommended in certain situations. Vaccination is recommended for individuals at risk of Hepatitis B exposure, including healthcare workers, people with multiple sexual partners, newborns of infected mothers, and individuals with certain medical conditions. Hepatitis B vaccination has been highly successful in preventing new infections and reducing the long-term risks associated with Hepatitis B, such as chronic liver disease and liver cancer.
The major global manufacturers of Hepatitis B Vaccines include GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, Serum Institute, LG Life Sciences, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Hepatitis B Vaccines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Hepatitis B Vaccines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Hepatitis B Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Hepatitis B Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Hepatitis B Vaccines Include:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
Serum Institute
LG Life Sciences
Hepatitis B Vaccines Product Segment Include:
Yeast Derived
CHO Derived
Hepatitis B Vaccines Product Application Include:
Children
Adult
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Hepatitis B Vaccines Industry PESTEL Analysis
Chapter 3: Global Hepatitis B Vaccines Industry Porter's Five Forces Analysis
Chapter 4: Global Hepatitis B Vaccines Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Hepatitis B Vaccines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Hepatitis B Vaccines Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Hepatitis B Vaccines Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Hepatitis B Vaccines Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Hepatitis B Vaccines Product by Type
- 1.2.1 Yeast Derived
- 1.2.2 CHO Derived
- 1.3 Hepatitis B Vaccines Product by Application
- 1.3.1 Children
- 1.3.2 Adult
- 1.4 Global Hepatitis B Vaccines Market Revenue and Sales Analysis
- 1.4.1 Global Hepatitis B Vaccines Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Hepatitis B Vaccines Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Hepatitis B Vaccines Market Sales Price Trend Analysis (2020-2032)
- 1.5 Hepatitis B Vaccines Market Development Status and Trends
- 1.5.1 Hepatitis B Vaccines Industry Development Status Analysis
- 1.5.2 Hepatitis B Vaccines Industry Development Trends Analysis
- 2 Hepatitis B Vaccines Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Hepatitis B Vaccines Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Hepatitis B Vaccines Market Analysis by Country
- 4.1 Global Hepatitis B Vaccines Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Hepatitis B Vaccines Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Hepatitis B Vaccines Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Hepatitis B Vaccines Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Hepatitis B Vaccines Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Hepatitis B Vaccines Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Hepatitis B Vaccines Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Hepatitis B Vaccines Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Hepatitis B Vaccines Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Hepatitis B Vaccines Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Hepatitis B Vaccines Average Sales Price by Manufacturers (2021-2025)
- 5.2 Hepatitis B Vaccines Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Hepatitis B Vaccines Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Hepatitis B Vaccines Market Analysis by Type
- 6.1 Global Hepatitis B Vaccines Market Revenue Analysis by Type
- 6.1.1 Global Hepatitis B Vaccines Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Hepatitis B Vaccines Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Hepatitis B Vaccines Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Hepatitis B Vaccines Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 GSK
- 7.1.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 GSK Hepatitis B Vaccines Product Portfolio
- 7.1.3 GSK Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 NCPC
- 7.2.1 NCPC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 NCPC Hepatitis B Vaccines Product Portfolio
- 7.2.3 NCPC Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Merck
- 7.3.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Merck Hepatitis B Vaccines Product Portfolio
- 7.3.3 Merck Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Bio Kangtai
- 7.4.1 Bio Kangtai Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Bio Kangtai Hepatitis B Vaccines Product Portfolio
- 7.4.3 Bio Kangtai Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Dynavax
- 7.5.1 Dynavax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Dynavax Hepatitis B Vaccines Product Portfolio
- 7.5.3 Dynavax Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Hissen
- 7.6.1 Hissen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Hissen Hepatitis B Vaccines Product Portfolio
- 7.6.3 Hissen Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 KM Biologics
- 7.7.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 KM Biologics Hepatitis B Vaccines Product Portfolio
- 7.7.3 KM Biologics Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Serum Institute
- 7.8.1 Serum Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Serum Institute Hepatitis B Vaccines Product Portfolio
- 7.8.3 Serum Institute Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 LG Life Sciences
- 7.9.1 LG Life Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 LG Life Sciences Hepatitis B Vaccines Product Portfolio
- 7.9.3 LG Life Sciences Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Hepatitis B Vaccines Industry Chain Analysis
- 8.2 Hepatitis B Vaccines Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Hepatitis B Vaccines Product Downstream Application Analysis
- 8.3.1 Global Hepatitis B Vaccines Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Hepatitis B Vaccines Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Hepatitis B Vaccines Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Hepatitis B Vaccines Typical Downstream Customers
- 8.5 Hepatitis B Vaccines Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
